On Feb. 8th SEPTA (Southeastern Pennsylvania Transportation Authority) will unveil its complete security prevention technology including the new Siegma System from HiEnergy Technogies. The Speakers below will discuss and demonstrate live, how this technology will work to protect its passengers from Terror and ultimately keep its stations from unnecessary evacuations and thus high cost set backs. SEPTA would like to invite you to attend a press conference on Feb. 8th at 11:00 am at the Market East Station (Details Below). Please let me know if you will be available to attend. Explosive detection system debuts at Southeastern Pennsylvania Transportation Authority (SEPTA) HiEnergy Technologies’SIEGMATM 3E3, the world’s first AtometricTM explosive detector will debut on Feb. 8 at Southeastern Pennsylvania Transportation Authority (SEPTA). SEPTA, which operates and provides security to the nation’s fifth largest transportation system, will demonstrate the extraordinary capabilities of the SIEGMATM 3E3 and explain how its deployment along with their K-9 units provides unprecedented safety and efficiency to public transportation. Attendees will include regional transportation, law enforcement and security officials, as well as local and national media. Dr. Bogdan Maglich, CEO & Chief Scientific Officer of HiEnergy Technologies, will discuss the advantages of the SIEGMATM 3E3 explosive detection system and explain how its ground-breaking product and technology differ from any other available to homeland security and counter-terrorism professionals. HiEnergy Technologies, Inc. is the creator of the world’s first “stoichiometric” or ‘AtometricTM”diagnostic devices that can effectively decipher chemical formulas of unknown substances through metal or other barriers, almost instantly and without human intervention. HiEnergy’s SIEGMATM 3E3 is unique in that it can detect and confirm whether an object or container carries a select group of dangerous or illicit substances, such as explosives, biological agents, or illicit drugs, with a probability of detection equal to approximately 97.75%, and “false negative” and “false positive” rates of nearly 2.25%.